Debt Securities, Available-for-Sale, Unrealized Loss Position
CVS Health·Products & Services·2 segments·Rolls up to Debt Securities, Available-for-Sale, Unrealized Loss Position
Breakdown
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Supporting Remaining Products | $13.82B | $14.56B | $7.21B | $12.84B | $9.60B | $6.40B | $5.25B | $6.13B |
| Supporting Experience Rated Products | $420.00M | $442.00M | $246.00M | $396.00M | $304.00M | $245.00M | $189.00M | $204.00M |
| Total | $14.24B | $15.00B | $7.46B | $13.24B | $9.90B | $6.65B | $5.44B | — |
Segments
Supporting Experience Rated ProductsView metric
Supporting Remaining ProductsView metric